UV Flu Technologies, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UVFT research report →
Companywww.uvflutech.com
UV Flu Technologies, Inc. engages in the research, development, manufacture, and sale of air purification systems and products primarily in the United States. Its flagship product is the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation inside a killing chamber that goes beyond filtering to trap and destroy harmful microbes.
- CEO
- Michael S. Ross
- IPO
- 2009
- Employees
- 1
- HQ
- Lincolnshire, IL, US
Price Chart
Valuation
- Market Cap
- $26.83K
- P/E
- -0.02
- P/S
- 0.15
- P/B
- -0.02
- EV/EBITDA
- -0.38
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 11.34%
- Op Margin
- -529.85%
- Net Margin
- -539.37%
- ROE
- 137.79%
- ROIC
- 252.21%
Growth & Income
- Revenue
- $175.51K · 54.31%
- Net Income
- $-946,666 · 4.70%
- EPS
- $-0.01 · 18.88%
- Op Income
- $-929,953
- FCF YoY
- 11.27%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -44.88
- Avg Volume
- 19.61K
Get TickerSpark's AI analysis on UVFT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our UVFT Coverage
We haven't published any research on UVFT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate UVFT Report →